Briones A, Del Estal L, Villa-Gomez C, Bermejo V, Cervera I, Gutierrez-Huerta P
Int J Mol Sci. 2025; 26(2).
PMID: 39859310
PMC: 11765243.
DOI: 10.3390/ijms26020595.
Czyzyk D, Yan W, Messing S, Gillette W, Tsuji T, Yamaguchi M
Nat Commun. 2025; 16(1):525.
PMID: 39788953
PMC: 11718114.
DOI: 10.1038/s41467-024-55766-x.
Healy F, Turner A, Marensi V, MacEwan D
Front Pharmacol. 2024; 15:1441938.
PMID: 39372214
PMC: 11450236.
DOI: 10.3389/fphar.2024.1441938.
Moorwood K, Smith F, Garfield A, Cowley M, Holt L, Daly R
BMC Biol. 2024; 22(1):221.
PMID: 39343875
PMC: 11441139.
DOI: 10.1186/s12915-024-02018-5.
Thatikonda V, Lyu H, Jurado S, Kostyrko K, Bristow C, Albrecht C
Nat Cancer. 2024; 5(9):1352-1370.
PMID: 39103541
PMC: 11424490.
DOI: 10.1038/s43018-024-00800-6.
Functional and structural insights into RAS effector proteins.
Mozzarelli A, Simanshu D, Castel P
Mol Cell. 2024; 84(15):2807-2821.
PMID: 39025071
PMC: 11316660.
DOI: 10.1016/j.molcel.2024.06.027.
RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations.
Bonsor D, Simanshu D
Annu Rev Cancer Biol. 2024; 8:97-113.
PMID: 38882927
PMC: 11178279.
DOI: 10.1146/annurev-cancerbio-062822-030450.
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome-associated cardiac hypertrophy.
Cuevas-Navarro A, Wagner M, Van R, Swain M, Mo S, Columbus J
Sci Adv. 2023; 9(28):eadf4766.
PMID: 37450595
PMC: 10348673.
DOI: 10.1126/sciadv.adf4766.
Structural insights into the role of SHOC2-MRAS-PP1C complex in RAF activation.
Bonsor D, Simanshu D
FEBS J. 2023; 290(20):4852-4863.
PMID: 37074066
PMC: 10584989.
DOI: 10.1111/febs.16800.
Probing mutation-induced conformational transformation of the GTP/M-RAS complex through Gaussian accelerated molecular dynamics simulations.
Bao H, Wang W, Sun H, Chen J
J Enzyme Inhib Med Chem. 2023; 38(1):2195995.
PMID: 37057639
PMC: 10114971.
DOI: 10.1080/14756366.2023.2195995.
The molecular genetics of RASopathies: An update on novel disease genes and new disorders.
Tartaglia M, Aoki Y, Gelb B
Am J Med Genet C Semin Med Genet. 2022; 190(4):425-439.
PMID: 36394128
PMC: 10100036.
DOI: 10.1002/ajmg.c.32012.
Afadin couples RAS GTPases to the polarity rheostat Scribble.
Goudreault M, Gagne V, Jo C, Singh S, Killoran R, Gingras A
Nat Commun. 2022; 13(1):4562.
PMID: 35931706
PMC: 9355967.
DOI: 10.1038/s41467-022-32335-8.
Bacterial Toxin and Effector Regulation of Intestinal Immune Signaling.
Woida P, Satchell K
Front Cell Dev Biol. 2022; 10():837691.
PMID: 35252199
PMC: 8888934.
DOI: 10.3389/fcell.2022.837691.
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.
Hortal A, Oeste C, Cifuentes C, Alcoceba M, Fernandez-Pisonero I, Clavain L
Mol Cancer. 2022; 21(1):35.
PMID: 35120522
PMC: 8815240.
DOI: 10.1186/s12943-022-01496-x.
Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors.
Lai L, Fer N, Burgan W, Wall V, Xu B, Soppet D
Proc Natl Acad Sci U S A. 2022; 119(5).
PMID: 35091470
PMC: 8812530.
DOI: 10.1073/pnas.2113491119.
A Structure is Worth a Thousand Words: New Insights for RAS and RAF Regulation.
Simanshu D, Morrison D
Cancer Discov. 2022; 12(4):899-912.
PMID: 35046094
PMC: 8983508.
DOI: 10.1158/2159-8290.CD-21-1494.
Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling.
Zhang B, Luk C, Valadares J, Aronis C, Foukas L
Int J Mol Sci. 2021; 22(23).
PMID: 34884613
PMC: 8657683.
DOI: 10.3390/ijms222312813.
Loss of the wild-type KRAS allele promotes pancreatic cancer progression through functional activation of YAP1.
Yan H, Yu C, Fine S, Youssof A, Yang Y, Yan J
Oncogene. 2021; 40(50):6759-6771.
PMID: 34663879
PMC: 8688281.
DOI: 10.1038/s41388-021-02040-9.
Clinical and Cytometric Study of Immune Involvement in a Heterogeneous Cohort of Subjects With RASopathies and mTORopathies.
Valencic E, Da Lozzo P, Tornese G, Ghirigato E, Facca F, Piscianz E
Front Pediatr. 2021; 9:703613.
PMID: 34485194
PMC: 8414575.
DOI: 10.3389/fped.2021.703613.
RASSF9 promotes NSCLC cell proliferation by activating the MEK/ERK axis.
Yuan J, Ju Q, Zhu J, Jiang Y, Yang X, Liu X
Cell Death Discov. 2021; 7(1):199.
PMID: 34341331
PMC: 8329231.
DOI: 10.1038/s41420-021-00583-0.